Guided Therapeutics (GTHP) Profit After Tax (QoQ) (2011 - 2025)
Guided Therapeutics (GTHP) Profit After Tax (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.78 Mn | 20.72 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -64.15% |
| Sep 30, 2025 | 8.51% |
| Jun 30, 2025 | -189,829.74% |
| Mar 31, 2025 | 99.93% |
| Dec 31, 2024 | 0.31% |
| Sep 30, 2024 | 7.76% |
| Jun 30, 2024 | -176,268.16% |
| Mar 31, 2024 | 99.90% |
| Dec 31, 2023 | 42.98% |
| Sep 30, 2023 | 56.52% |
| Jun 30, 2023 | -79.17% |
| Mar 31, 2023 | 51.91% |
| Dec 31, 2022 | -63.97% |
| Sep 30, 2022 | -19.01% |
| Jun 30, 2022 | -82.64% |
| Mar 31, 2022 | -14.19% |
| Dec 31, 2021 | -752.94% |
| Sep 30, 2021 | 106.58% |
| Jun 30, 2021 | -100.00% |
| Mar 31, 2021 | -123.87% |